For instance, NDUFB1 mRNA was reported to be downregulated in aggressive ovarian cancers, suggesting a reduction in oxidative phosphorylation in high-risk tumors [16], whereas altered transcript levels were also detected in clear-cell renal cell carcinoma [17]. Here, NDUFB1 is linked to ovarian cancer.